(Q33490304)

English

Route of delivery and baseline left ventricular ejection fraction, key factors of bone-marrow-derived cell therapy for ischaemic heart disease

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

0 references

Route of delivery and baseline left ventricular ejection fraction, key factors of bone-marrow-derived cell therapy for ischaemic heart disease (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

arteriosclerotic heart disease

1 reference

based on heuristic

inferred from title

ejection fraction

1 reference

based on heuristic

inferred from title

3

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

author name string

Susan J Brunskill

1

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Christopher J Hyde

2

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Suzanne M Watt

4

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Enca Martin-Rendon

5

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

publication date

4 August 2009

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

European Journal of Heart Failure

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

887-896

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Stem cell-related therapies for vascular diseases

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP101

21 January 2018

Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP101

21 January 2018

5-Azacytidine-treated human mesenchymal stem/progenitor cells derived from umbilical cord, cord blood and bone marrow do not generate cardiomyocytes in vitro at high frequencies

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP101

21 January 2018

Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP101

21 January 2018

Clinical applications of blood-derived and marrow-derived stem cells for nonmalignant diseases

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP101

21 January 2018

Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: a collaborative systematic review and meta-analysis of controlled clinical trials.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP101

21 January 2018

Clinical stem cell therapies for severe autoimmune diseases

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP101

21 January 2018

Stem cells and repair of the heart.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP101

21 January 2018

Bone marrow cells adopt the cardiomyogenic fate in vivo

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP101

21 January 2018

Adult cardiac stem cells are multipotent and support myocardial regeneration

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP101

21 January 2018

Iron particles for noninvasive monitoring of bone marrow stromal cell engraftment into, and isolation of viable engrafted donor cells from, the heart.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP101

21 January 2018

Bone marrow-derived stromal cells home to and remain in the infarcted rat heart but fail to improve function: an in vivo cine-MRI study.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP101

21 January 2018

Improved exercise capacity and ischemia 6 and 12 months after transendocardial injection of autologous bone marrow mononuclear cells for ischemic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP101

21 January 2018

Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: a phase I/IIa double-blind, randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP101

21 January 2018

Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP101

21 January 2018

Systematic reviews in health care: Assessing the quality of controlled clinical trials

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP101

21 January 2018

Effects of stem cell therapy with G-CSF on coronary artery after drug-eluting stent implantation in patients with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP101

21 January 2018

Differential effect of intracoronary infusion of mobilized peripheral blood stem cells by granulocyte colony-stimulating factor on left ventricular function and remodeling in patients with acute myocardial infarction versus old myocardial infarction

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP101

21 January 2018

Three-, 6-, and 12-month results of autologous transplantation of mononuclear bone marrow cells in patients with acute myocardial infarction.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP101

21 January 2018

Randomized, controlled trial of intramuscular or intracoronary injection of autologous bone marrow cells into scarred myocardium during CABG versus CABG alone

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP101

21 January 2018

Transplantation of blood-derived progenitor cells after recanalization of chronic coronary artery occlusion: first randomized and placebo-controlled study

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP101

21 January 2018

Surgical treatment for congestive heart failure with autologous adult stem cell transplantation: a prospective randomized study

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP101

21 January 2018

Recovery of regional but not global contractile function by the direct intramyocardial autologous bone marrow transplantation: results from a randomized controlled clinical trial.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP101

21 January 2018

Prospective randomized trial of direct endomyocardial implantation of bone marrow cells for treatment of severe coronary artery diseases (PROTECT-CAD trial).

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP101

21 January 2018

Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP101

21 January 2018

Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP101

21 January 2018

Intracoronary Bone Marrow–Derived Progenitor Cells in Acute Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP101

21 January 2018

Efficacy of emergent transcatheter transplantation of stem cells for treatment of acute myocardial infarction (TCT-STAMI).

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP101

21 January 2018

Administration of intracoronary bone marrow mononuclear cells on chronic myocardial infarction improves diastolic function

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP101

21 January 2018

Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP101

21 January 2018

Bone marrow cells regenerate infarcted myocardium

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP101

21 January 2018

Cardioprotective c-kit+ cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP101

21 January 2018

Sustained persistence of transplanted proangiogenic cells contributes to neovascularization and cardiac function after ischemia

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP101

21 January 2018

Pilot trial on determinants of progenitor cell recruitment to the infarcted human myocardium.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP101

21 January 2018

Acute myocardial infarction in swine rapidly and selectively releases highly proliferative endothelial colony forming cells (ECFCs) into circulation

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP101

21 January 2018

Evolution of the c-kit-positive cell response to pathological challenge in the myocardium

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP101

21 January 2018

CD117-positive cells in adult human heart are localized in the subepicardium, and their activation is associated with laminin-1 and alpha6 integrin expression

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP101

21 January 2018

Selective functional exhaustion of hematopoietic progenitor cells in the bone marrow of patients with postinfarction heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP101

21 January 2018

Cell isolation procedures matter: a comparison of different isolation protocols of bone marrow mononuclear cells used for cell therapy in patients with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP101

21 January 2018

Transcoronary transplantation of progenitor cells after myocardial infarction

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP101

21 January 2018

Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP101

21 January 2018

Identifiers

10.1093/EURJHF/HFP101

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33490304&oldid=1956308656"